SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-020016
Filing Date
2018-03-15
Accepted
2018-03-15 19:59:04
Documents
1
Period of Report
2018-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4091
  Complete submission text file 0001209191-18-020016.txt   5791
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROGESX INC. 981 INDUSTRIAL ROAD SUITE F SAN CARLOS CA 94070
Business Address
Ghiglieri Stephen F (Reporting) CIK: 0001394548 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 18693923